The metastatic pheochromocytoma has no curative treatments unless the site of disease is surgically resectable.Â Ten percent of all catecholamine-secreting tumors are malignant and are histologically and biochemically the same as benign tumors.

Palliative chemotherapy includes cyclophosphamide, vincristine, dacarbazine, and temozolomide, along with other symptomatic therapy can increase the median survival from 2 to 26 months.